Hakeem Jeffries blasts Republican who confronted him on shutdown bill Wyoming library director fired amid book dispute wins $700,000 settlement How to hard boil eggs without using water CNN reports ...
CD19 chimeric antigen receptor (CAR) T-cell therapy showed potential in treating patients with refractory systemic lupus erythematosus (SLE), with B-cell depletion and disease activity reduction ...
In a controversial step that raises the possibility of a new kind of infertility treatment, scientists report that they have produced functional human eggs in the lab that were able to be fertilized ...
DuoCAR20.19.22-D95 targets CD19, CD20, and CD22, addressing antigen escape in B-cell malignancies like B-ALL and B-NHL. Early-stage trials show no safety concerns for DuoCAR20.19.22-D95, with ongoing ...
CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, ...
The CD20 inhibitor Ocrevus (ocrelizumab) rapidly depletes immune B-cells in people with multiple sclerosis (MS), as expected, but ongoing treatment also leads to changes in immune T-cells, a new study ...
Scientists have uncovered a sweet twist in the body’s fight against cancer. Glucose, best known as the fuel that powers our cells, also helps immune cells called T cells communicate and organize their ...
How does a somewhat unheard 60s B-side eventually become one of the most iconic hits of the 1980s? “Tainted Love” took one of the most bizarre journeys ever from its humble origins to its belatedly ...
Background Intrahepatic cholangiocarcinoma (iCCA) is a highly aggressive biliary tract cancer with a poor prognosis and a complex tumour microenvironment (TME) that remains poorly understood.
Acute myeloid leukemia (AML) cells under the microscope, in purple. There is a serious need for finding better ways to treat AML that comes back after initial treatment. Chimeric antigen receptor (CAR ...
A new treatment for type 1 diabetes is moving closer to reality. In late 2024, a 46-year-old Swedish man received 17 injections of a unique pancreatic cell cocktail. The cells, donated from a healthy ...